| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.018 | 8.664 | 14.941 | 35.117 | 35.802 | 71.949 | 66.417 | 64.639 | 115.614 | 140.539 |
| Total Income - EUR | 6.019 | 8.665 | 30.331 | 35.246 | 46.484 | 87.792 | 66.600 | 64.639 | 127.346 | 144.171 |
| Total Expenses - EUR | 5.663 | 4.947 | 24.742 | 22.892 | 58.501 | 40.467 | 58.749 | 58.541 | 98.037 | 109.274 |
| Gross Profit/Loss - EUR | 357 | 3.718 | 5.589 | 12.354 | -12.017 | 47.325 | 7.850 | 6.098 | 29.309 | 34.897 |
| Net Profit/Loss - EUR | 176 | 3.458 | 4.681 | 11.858 | -12.482 | 46.497 | 7.264 | 5.567 | 28.210 | 32.233 |
| Employees | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 |
Check the financial reports for the company - Nadavi Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 503 | 363 | 19.854 | 21.023 | 20.500 | 45.196 | 94.896 | 93.306 | 110.762 | 106.314 |
| Current Assets | 1.031 | 5.545 | 5.839 | 3.917 | 29.226 | 41.876 | 53.245 | 60.227 | 67.941 | 91.036 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 170 | 26.427 | 8.618 | 8.570 |
| Receivables | 438 | 100 | 114 | 448 | 18.190 | 10.082 | 33.444 | 26.107 | 29.058 | 60.226 |
| Cash | 593 | 5.445 | 5.726 | 3.469 | 11.035 | 31.794 | 19.631 | 7.693 | 30.265 | 22.240 |
| Shareholders Funds | -1.352 | 2.119 | 6.764 | 18.451 | 5.612 | 52.003 | 58.113 | 63.860 | 91.877 | 123.597 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.886 | 3.789 | 18.989 | 6.596 | 44.218 | 36.974 | 90.324 | 89.673 | 86.826 | 73.753 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
8291
|
|||||||||
Comments - Nadavi Intermed Srl